000028 China National Accord Medicines Corporation
- 32.01
- +1.54+5.05%
China National Accord Medicines Corporation News
Sinopharm\'s agreement: Announcement of the resolution of the 3rd Interim Meeting of the 10th Board of Directors in 2024
Sinopharm agrees: Announcement of the resolution of the 2nd Interim Meeting of the 10th Board of Directors in 2024
Sinopharm Unanimity: Announcement on Senior Executives Retirement
Sinopharm\'s agreement: announcement on changes to accounting firms
Sinopharm agreement: announcement of the resolution of the first interim meeting of the 10th board of directors in 2024
Sinopharm Unanimity: Announcement on Senior Executives Retirement
Sinopharm Consistency: 000028 Sinopharm Investor Relations Management Information 20240903
Sinopharm\'s agreement: semi-annual report board resolution announcement
Sinopharm Conforms: Report on Continued Risk Assessment of Sinopharm Group Finance Co., Ltd.
Sinopharm Consistent: Semi-Annual Report Supervisory Board Resolutions Announcement
China National Accord Medicines Corporation: Announcement of Resolutions of the First Meeting of the Tenth Board of Directors.
China National Accord Medicines Corporation: Board of directors' compensation and assessment committee work system.
China National Accord Medicines Corporation: Work system of the board of directors' risk control and audit committee.
China National Accord Medicines Corporation: Working System of the Board of Directors Nomination Committee
China National Accord Medicines Corporation: Announcement of Resolutions of the First Meeting of the Tenth Board of Supervisors
China National Accord Medicines Corporation: Nominee Statement and Commitment (Jiang Bailin)
China National Accord Medicines Corporation: Nominee Statement and Commitment (Li Honghai)
China National Accord Medicines Corporation: Announcement of the resolution of the third extraordinary meeting of the ninth board of directors in 2024.
China National Accord Medicines Corporation: Statement and commitment of independent director candidate (Su Weiwei).
China National Accord Medicines Corporation: Nominee's Statement and Commitment (Bi Yalin)
Analysis
Price Target
No Data
No Data